DRIO
DarioHealth Corp

3,546
Mkt Cap
$81.56M
Volume
3,087.00
52W High
$31.00
52W Low
$5.94
PE Ratio
-0.67
DRIO Fundamentals
Price
$12.00
Prev Close
$12.05
Open
$12.00
50D MA
$13.94
Beta
1.04
Avg. Volume
32,299.47
EPS (Annual)
-$12.27
P/B
1.09
Rev/Employee
$133,861.39
Loading...
Loading...
News
all
press releases
Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio Dario's Data-Driven Digital Health Platform Delivers...
PR Newswire·1d ago
News Placeholder
More News
News Placeholder
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date PR Newswire NEW YORK...
PR Newswire·3d ago
News Placeholder
DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year DarioHealth Announces Publication of...
PR Newswire·11d ago
News Placeholder
DarioHealth Corp. (DRIO) Reports Q3 Loss, Lags Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of +29.66% and -12.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·22d ago
News Placeholder
DarioHealth Reports Third Quarter 2025 Financial and Operating Results
DarioHealth Reports Third Quarter 2025 Financial and Operating Results DarioHealth Reports Third Quarter 2025 Financial and Operating Results PR Newswire NEW YORK, Nov. 13, 2025 Third quarter 2025...
PR Newswire·22d ago
News Placeholder
Examining the Future: DarioHealth's Earnings Outlook
read more...
Benzinga·23d ago
News Placeholder
Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates
Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -66.67% and -6.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·23d ago
News Placeholder
DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform
DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform DarioHealth Presents New Data Demonstrating Significant...
PR Newswire·23d ago
News Placeholder
Si-Bone (SIBN) Reports Q3 Loss, Beats Revenue Estimates
Si-Bone (SIBN) delivered earnings and revenue surprises of +31.25% and +4.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·25d ago
News Placeholder
DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025
DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025 DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025 PR Newswire NEW YORK, Nov. 6, 2025...
PR Newswire·29d ago

Latest DRIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.